| Identification | Back Directory | [Name]
Immunoglobulin G1,anti-(human CD4 (antigen)) (human-mouse monoclonal cm-T412 g1-chain), disulfide withhuman-mouse monoclonal cm-T412 k-chain, dimer | [CAS]
147191-91-1 | [Synonyms]
Research Grade Priliximab
Immunoglobulin G1,anti-(human CD4 (antigen)) (human-mouse monoclonal cm-T412 g1-chain), disulfide withhuman-mouse monoclonal cm-T412 k-chain, dimer |
| Hazard Information | Back Directory | [Uses]
Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can be used in research of rheumatoid arthritis (RA)[1]. | [References]
[1] Salvatore A, et, al. Method for prediction of response to immune mediated disease therapeutics. US20130225427. |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|